Clinical trial
The Role of Drug Metabolizing Enzymes in the Pathogenesis Adverse Drug Reactions in Children
NCT00224952 is registered in ClinicalTrials.gov with Children's Mercy Hospital Kansas City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Drug Metabolizing Enzymes in the Pathogenesis Adverse Drug Reactions in Children
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- March 31, 2010
- Enrollment
- 274 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.